BioSpace News Archive

Karyopharm Therapeutics Inc. (Nasdaq:KPTI), today provided an update on its discussions with the U.S. Food and Drug Administration (FDA) regarding its previously planned supplemental New Drug Application (sNDA) submission based on the data from the Phase 3 SIENDO study evaluating selinexor as a front-line maintenance therapy following chemotherapy in patients with advanced or recurrent endometrial cancer.

REGENXBIO Inc. (Nasdaq: RGNX) today announced financial results for the fourth quarter ended December 31, 2021, and recent operational highlights.

MEI Pharma, Inc., a late-stage pharmaceutical company focused on advancing new therapies for cancer, announced the grant of inducement stock options for an aggregate of 210,000 shares of the company’s common stock to four new employees.

Certara, Inc., a global leader in biosimulation, reported its financial results for the fourth quarter and full year of 2021 and updated guidance for 2022.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that management will present at Cowen’s 42nd Annual Health Care Conference on Tuesday, March 8, 2022 at 2:50 p.m. ET.

Zomedica Corp., a veterinary health company offering diagnostic and therapeutic products for companion animals, reported consolidated financial results for the year ended December 31, 2021.

IASO Biotherapeutics (“IASO Bio”), announced that the company’s commercial manufacturing facility in Nanjing successfully passed a comprehensive inspection by the Medical Products Administration of Province Jiangsu (JSMPA) and was granted a drug manufacturing license.

When a fluid travels through an hourglass-shaped pipe, there is a reduction in pressure of the fluid in the throat of the pipe, and the velocity of the fluid increases in the throat area, this is known as the Venturi effect.

Thalassemia is a type of hereditary blood disorder in which an abnormal form of hemoglobin is produced by the human body.

The demand within the global stroke assistive devices market is anticipated to grow at a stupendous pace in the times to follow.